Recent Comments

Comment RSS

Virus News and Research RSS Feed - Virus News and Research

A virus is a microscopic infectious agent that can reproduce only inside a host cell. Viruses infect all types of organisms: from animals and plants, to bacteria and archaea. Since the initial discovery of tobacco mosaic virus by Martinus Beijerinck in 1898, more than 5,000 types of virus have been described in detail, although most types of virus remain undiscovered. Viruses are ubiquitous, as they are found in almost every ecosystem on Earth, and are the most abundant type of biological entity on the planet. The study of viruses is known as virology, and is a branch of microbiology.

Inovio Biomedical announces positive test results of its consensus influenza vaccines

20. November 2009 06:39
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets. [More]

Physicists observe experimental evidence for directed percolation

20. November 2009 04:44
A team of physicists has, for the first time, seen convincing experimental evidence for directed percolation, a phenomenon that turns up in computer models of the ways diseases spread through a population or how water soaks through loose soil. Their observation strengthens the case for directed percolation's relevance to real systems, and lends new vigor to long-standing theories about how it works. Their experiment is reported in Physical Review E and highlighted with a Viewpoint in the November 16 issue of Physics (http://physics.aps.org). [More]

Posted in: Device / Technology News | Disease/Infection News

Tags: ,

LAIV and TIV vaccines appear to offer protection against A/H1N1 virus

20. November 2009 04:19
Immunization with either live attenuated influenza vaccine (LAIV, also known as FluMist®), or trivalent inactivated influenza vaccine (TIV), appears to offer a protection (~ 45%) against the novel A/H1N1 virus, the cause of the present influenza pandemic. However, the benefit was largely attributed to the youngest age group. The finding emerges from an evaluation of medical encounters and seasonal influenza immunization of U.S. military service members. [More]

Posted in: Disease/Infection News | Pharmaceutical News

Tags: , , , , , ,

University of Michigan scientists discover how SEVI works

20. November 2009 04:02
Since the discovery in 2007 that a component of human semen called SEVI boosts infectivity of the virus that causes AIDS, researchers have been trying to learn more about SEVI and how it works, in hopes of thwarting its infection-promoting activity. [More]

Posted in: Medical Science News | Disease/Infection News

Tags: , , , , , , , , ,

Scientists anticipate new approaches in drug development to combat prion infection

20. November 2009 03:22
The regulating protein Srebp2 drives cholesterol formation, which prions need for their propagation, in prion-infected neuronal cells. With these findings, published in the current issue of the Journal of Biological Chemistry, scientists of Helmholtz Zentrum München and Technische Universität München anticipate new approaches in drug development to combat prion infection. [More]

Posted in: Medical Science News | Medical Condition News

Tags: , , , , ,

Discoveries on anti-HIV antibodies may help researchers create an effective HIV vaccine

20. November 2009 02:59
New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. [More]

Posted in: Disease/Infection News | Pharmaceutical News

Tags: , , , ,

Pediatric immunologist receives prestigious annual award from American Philosophical Society

20. November 2009 02:27
A pediatric immunologist at The Children's Hospital of Philadelphia has received a prestigious annual award from the American Philosophical Society, an organization founded in 1743 by Benjamin Franklin. Jordan S. Orange, M.D., Ph.D., received the Society's Judson Daland Prize on Nov. 13 for his contributions to research and treatment of inherited immune deficiency diseases. [More]

Hepatitis C Virus therapeutics development landscape continues to inflate

20. November 2009 01:06
Research and Markets (http://www.researchandmarkets.com/research/f6bf5e/hepatitis_c_virus) has announced the addition of the "Hepatitis C Virus And Therapeutics - A Global Update of Market Trends & Opportunities" report to their offering. [More]

Posted in: Disease/Infection News | Pharmaceutical News

Tags: , , ,

H1N1: Bridging the knowledge gap

20. November 2009 00:52
A commentary in the December issue of The Lancet Infectious Diseases brings to light the gaps in knowledge on the transmission of a common pathogen - the influenza virus - and its impact on decisions about how best to protect health care workers. Infectious diseases specialist Leonard Mermel, DO, medical director of infection control for Rhode Island Hospital, looks at the ongoing debate in light of the H1N1 pandemic, what past research tells us about the spread of influenza, and what is missing in the debate. His commentary is currently available in an online first edition. [More]

Researchers to discover new vaccine against infection from Lyme disease

20. November 2009 00:30
A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. [More]

Posted in: Disease/Infection News

Tags: , , , , , ,

Adamas Pharmaceuticals expands its Phase 2 TCAD therapy study for influenza A

19. November 2009 09:35
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has expanded its Phase 2 clinical study of a proprietary investigational triple-combination antiviral drug therapy for influenza to include centers in the United States, Canada and Europe. The study, which was initiated in August 2009 in the Southern Hemisphere, is designed to investigate Adamas' triple combination antiviral drug (TCAD) therapy as a treatment for influenza A, including novel influenza A/H1N1, the cause of the current flu pandemic. [More]

Posted in: Drug Trial News | Disease/Infection News

Tags: , , , , , ,

SinoFresh Nasal Spray effective against 'swine flu' in animal study

19. November 2009 07:55
SinoFresh Healthcare Products, Inc. announced today the successful results of its initial pilot animal study testing the efficacy of the SinoFresh Nasal Spray product when used on animals infected with the H1N1 virus. The study data suggests that treatment with SinoFresh allowed the infected animals to recover more rapidly from H1N1 infection than did untreated animals. In addition, pre-treatment with SinoFresh Nasal Spray decreased the severity and/or incidence of infection. [More]

Posted in: Device / Technology News | Disease/Infection News

Tags: , ,

Exaggerated responses of immune system explain elders’ susceptibility to viral infections

19. November 2009 07:01
Researchers at Yale School of Medicine have found that exaggerated responses of the immune system explain why the elderly succumb to viral infections more readily than younger people. Published in the November 19 Cell Host & Microbe, the study bucks the general belief that declining immune responses are to blame for susceptibility to viral infections. [More]

Posted in: Disease/Infection News

Tags: , , , , , , ,

NPSF supports obligatory flu vaccination for healthcare workers

19. November 2009 06:14
The National Patient Safety Foundation recognizes vaccine-preventable diseases as a matter of patient safety and supports mandatory influenza vaccination of health care workers to protect the health of patients, health care workers, and the community. [More]

Posted in: Disease/Infection News | Healthcare News | Pharmaceutical News

Tags: , , ,

Genetic identity of cellular receptor for the immune system's first-response antibody discovered

19. November 2009 06:00
Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. The discovery is such a crucial part of immunology that UAB researchers, in conjunction with Japanese researchers, are asking that the gene linked to this antibody receptor be renamed to better describe its role in early immune responses. [More]

Posted in: Medical Science News

Tags: , , , , , , , , ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.